Next-Generation Imaging

Latest News

Dr. Dallos discusses emerging treatments in the mCRPC paradigm
Dr. Dallos discusses emerging treatments in the mCRPC paradigm

March 22nd 2023

Antibody-drug conjugates, including those targeting PSMA, are among the next wave of treatment advances in mCRPC.

FDA approves new indication for Illuccix in metastatic prostate cancer
FDA approves new indication for Illuccix in metastatic prostate cancer

March 16th 2023

blurred image of a clinic hallway
PSMA-PET may lead to treatment delays that unintentionally harm patients with prostate cancer

March 8th 2023

Imaging agent 64Cu-SAR-bisPSMA effective in treatment-naive prostate cancer
Imaging agent 64Cu-SAR-bisPSMA effective in treatment-naive prostate cancer

February 24th 2023

Analysis underscores value of piflufolastat F 18 in recurrent prostate cancer with low PSA levels
Analysis underscores value of piflufolastat F 18 in recurrent prostate cancer with low PSA levels

February 23rd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.